Patent holdings for IPC class A61K 31/559

Total number of patents in this class: 56

10-year publication summary

7
6
5
4
6
7
0
4
2
2
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Allergan, Inc.
2146
19
Alcon, Inc.
5930
10
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
879
2
Bristol-myers Squibb Company
4761
1
The Regents of the University of California
20924
1
Alexion Pharmaceuticals, Inc.
648
1
Beijing Molecule Science and Technology Co., Ltd.
5
1
Beth Israel Deaconess Medical Center, Inc.
852
1
Cayman Chemical Company, Incorporated
58
1
C.t.g. Pharma S.r.l.
5
1
ImClone LLC
60
1
ImmunoGen, Inc.
376
1
Institut National de La Sante et de La Recherche Medicale (inserm)
3313
1
Jiangsu Simcere Pharmaceutical Co., Ltd
125
1
Katholieke Universiteit Leuven
1304
1
Latvian Institute of Organic Synthesis
52
1
Ono Pharmaceutical Co., Ltd.
420
1
Osaka University
3252
1
Polyactiva Pty Ltd
27
1
Pusan National University Industry-University Cooperation Foundation
759
1
Other owners 8